These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Autoimmune Attack of the Neuromuscular Junction in Myasthenia Gravis: Nicotinic Acetylcholine Receptors and Other Targets. Paz ML; Barrantes FJ ACS Chem Neurosci; 2019 May; 10(5):2186-2194. PubMed ID: 30916550 [TBL] [Abstract][Full Text] [Related]
11. Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment. Pachner AR Yale J Biol Med; 1987; 60(2):169-77. PubMed ID: 3495075 [TBL] [Abstract][Full Text] [Related]
12. Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis. Lagoumintzis G; Zisimopoulou P; Kordas G; Lazaridis K; Poulas K; Tzartos SJ Autoimmunity; 2010 Aug; 43(5-6):436-45. PubMed ID: 20187712 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic immunoadsorption of acetylcholine receptor antibodies in myasthenia gravis. Sato T; Ishigaki Y; Komiya T; Tsuda H Ann N Y Acad Sci; 1988; 540():554-6. PubMed ID: 3061349 [No Abstract] [Full Text] [Related]
14. Possible strategies for the treatment of myasthenia gravis and other autoimmune diseases. Nossal GJ Ann N Y Acad Sci; 1987; 505():610-8. PubMed ID: 3500669 [No Abstract] [Full Text] [Related]
16. Current trends in the management of myasthenia gravis: plasmapheresis and immunosuppressive therapy. Pollard JD; Basten A; Hassall JE; Kronenberg H; Cobcroft R; Dawkins R Aust N Z J Med; 1980 Apr; 10(2):212-7. PubMed ID: 6930213 [TBL] [Abstract][Full Text] [Related]
17. Maintenance immunosuppression in myasthenia gravis. Gotterer L; Li Y J Neurol Sci; 2016 Oct; 369():294-302. PubMed ID: 27653912 [TBL] [Abstract][Full Text] [Related]
18. Effect of thymectomy on cellular immunity in myasthenia gravis. Tronconi BC; Morgutti M; Cornelio F; Clementi F Lancet; 1978 Jan; 1(8054):46-7. PubMed ID: 74527 [No Abstract] [Full Text] [Related]